Post Reply
1641-1660 of 1767
Any news on whether EPF is still selling?
ss2017. ( Date: 14-Dec-2020 10:28) Posted:
| Today it drops 7% is a lot of selling but volume is not big |
|
meaning?
Sgvale ( Date: 14-Dec-2020 10:22) Posted:
| Still at $2.56. Wow. consider the earlier share spilt |
|
Today it drops 7% is a lot of selling but volume is not big
Still at $2.56. Wow. consider the earlier share spilt
boke 60ct...support 42ct....all covid counters downtrend....bcareful....
This counter is a huge disappointment!
Why sound so happy, its only 1 blardee cent...
boyboy61 ( Date: 11-Dec-2020 16:49) Posted:
why sudden buyup from 0.605 to 0.615 in 2-3 minutes
Longtermer ( Date: 11-Dec-2020 11:53) Posted:
Another 2 weeks plus to close the Q2 accounts.
Expected another record jump in rev and profits when UG results release in Feb21.
Hope to see dividends announcement as well.
Current trading at about 3.8 times PE FY21.
Is it good value?
No other glove companies can beat this imo..
|
|
|
|
Time for UG to move
Its share price consolidates at 60.5 for about a week. If 60.5 stays, likely it will stay there then 70c is the next target.
If 60.5 fails next week, we can look for 56c. Get your Christmas shopping bags ready!!
boyboy61 ( Date: 11-Dec-2020 16:49) Posted:
why sudden buyup from 0.605 to 0.615 in 2-3 minutes
Longtermer ( Date: 11-Dec-2020 11:53) Posted:
Another 2 weeks plus to close the Q2 accounts.
Expected another record jump in rev and profits when UG results release in Feb21.
Hope to see dividends announcement as well.
Current trading at about 3.8 times PE FY21.
Is it good value?
No other glove companies can beat this imo..
|
|
|
|
why sudden buyup from 0.605 to 0.615 in 2-3 minutes
Longtermer ( Date: 11-Dec-2020 11:53) Posted:
Another 2 weeks plus to close the Q2 accounts.
Expected another record jump in rev and profits when UG results release in Feb21.
Hope to see dividends announcement as well.
Current trading at about 3.8 times PE FY21.
Is it good value?
No other glove companies can beat this imo..
eric998 ( Date: 11-Dec-2020 08:24) Posted:
| Very high chance to move up near results dates then after results price will drop |
|
|
|
Another 2 weeks plus to close the Q2 accounts.
Expected another record jump in rev and profits when UG results release in Feb21.
Hope to see dividends announcement as well.
Current trading at about 3.8 times PE FY21.
Is it good value?
No other glove companies can beat this imo..
eric998 ( Date: 11-Dec-2020 08:24) Posted:
Very high chance to move up near results dates then after results price will drop?
FreedomAngelz ( Date: 10-Dec-2020 18:25) Posted:
| I`m still holding my 40 lot (40000) shares. Hopefully the price climb above $0.70 when they announce their next result and completion of their next factory. |
|
|
|
| # |
Country,
Other |
Total
Cases |
New
Cases |
Total
Deaths |
New
Deaths |
Total
Recovered |
Active
Cases |
Serious,
Critical |
Tot Cases/
1M pop |
Deaths/
1M pop |
Total
Tests |
Tests/
1M pop |
Population |
| |
World |
70,700,291 |
+678,684 |
1,587,608 |
+12,669 |
49,134,006 |
19,978,677 |
106,717 |
9,070 |
203.7 |
|
|
|
| 1 |
USA |
16,039,393 |
+217,779 |
299,692 |
+2,974 |
9,330,865 |
6,408,836 |
27,352 |
48,331 |
903 |
215,116,047 |
648,203 |
331,865,090 |
| 2 |
Brazil |
6,783,543 |
+53,425 |
179,801 |
+769 |
5,931,777 |
671,965 |
8,318 |
31,813 |
843 |
25,700,000 |
120,527 |
213,230,064 |
| 3 |
India |
9,796,992 |
+34,666 |
142,222 |
+487 |
9,290,188 |
364,582 |
8,944 |
7,068 |
103 |
150,759,726 |
108,772 |
1,386,012,075 |
| 4 |
Turkey |
1,748,567 |
+30,424 |
15,751 |
+220 |
1,154,333 |
578,483 |
5,943 |
20,634 |
186 |
20,500,579 |
241,922 |
84,740,585 |
| 5 |
Germany |
1,270,432 |
+28,179 |
21,233 |
+529 |
922,100 |
327,099 |
4,339 |
15,142 |
253 |
30,494,036 |
363,443 |
83,903,248 |
| 6 |
Russia |
2,569,126 |
+27,927 |
45,280 |
+562 |
2,033,669 |
490,177 |
2,300 |
17,601 |
310 |
81,021,364 |
555,084 |
145,962,393 |
| 7 |
UK |
1,787,783 |
+20,964 |
63,082 |
+516 |
N/A |
N/A |
1,243 |
26,274 |
927 |
46,730,999 |
686,771 |
68,044,545 |
| 8 |
Italy |
1,787,147 |
+16,999 |
62,626 |
+887 |
1,027,994 |
696,527 |
3,291 |
29,578 |
1,036 |
23,676,174 |
391,846 |
60,422,081 |
| 9 |
France |
2,337,966 |
+13,750 |
56,940 |
+292 |
174,658 |
2,106,368 |
2,959 |
35,783 |
871 |
28,282,874 |
432,871 |
65,337,886 |
| 10 |
Poland |
1,102,096 |
+13,749 |
21,630 |
+470 |
792,119 |
288,347 |
1,775 |
29,134 |
572 |
6,586,361 |
174,113 |
37,828,086 |
Unigloves Fortified BioCote Antimicrobial Gloves
► Europe' s first nitrile examination glove with antimicrobial protection
► Kills up to 99.9% of bacteria
Designed to mitigate risks of cross-contamination
Incorporating silver ion technology from BioCote
Unigloves Fortified gloves contain BioCote® with proven antimicrobial protection.
BioCote is silver ion technology. It has been used in the manufacture of Unigloves Fortified gloves to provide antimicrobial properties. Ionic silver particles are impregnated throughout the rubber nitrile during glove production.
Why Silver?
Silver has been used for centuries for its abilities to aid preservation, for example, the ancient Greeks used silver vessels to keep their water fresh. Silver is an ideal antimicrobial agent due to its effectiveness against a range of microorganisms.
How does Silver work in gloves?
Silver ions are present at the surface of the glove and are available to act against contaminating microbes. The silver ions bind with and irreparably damage their cells disrupt normal functions essential to survival stopping them from reproducing and rendering them harmless.
Destroys 99.9% of bacteria
Scientifically proven results have shown that BioCote treated materials destroy 99.9% of bacteria they come into contact with.
Fortified Blue Nitrile &ndash antimicrobial nitrile gloves
Code: P-GF001X
Fortified nitrile gloves are:
Effective
Fortified gloves are protected from colonisation by microbes, enhance hygiene and are a more hygienic alternative to standard nitrile examination gloves.
Long-lasting
Fortified gloves maintain their antimicrobial protection for the lifetime of the glove.
Proven
Fortified gloves have been shown to be effective against all types of bacteria. BioCote silver ion technology has been proven to materially reduce microbes by up to 99.5%.
Accredited
BioCote silver antimicrobial technology is considered food-safe and a suitable addition to food contact articles.
Top Glove: Average glove prices to be 30% higher in 2Q
https://www.theedgemarkets.com/article/top-glove-average-glove-prices-be-30-higher-2q
What do you think about UG? I believe UG also ASP 30% higher in 2Q
Very high chance to move up near results dates then after results price will drop?
FreedomAngelz ( Date: 10-Dec-2020 18:25) Posted:
| I`m still holding my 40 lot (40000) shares. Hopefully the price climb above $0.70 when they announce their next result and completion of their next factory. |
|
Riverstone n UG financial result in feb next year...top glove result released yesdy v good...
I`m still holding my 40 lot (40000) shares. Hopefully the price climb above $0.70 when they announce their next result and completion of their next factory.
Always remember the quote from Warren Buffett countless times: " Be fearful when others are greedy, and be greedy only when others are fearful"
UG may take off soon, this company has the best quarterly performance ever.
Investing.com -- U.K. regulators flag allergic reactions to the Pfizer/Biontech vaccine. DoorDash raises nearly $3.4 billion in a blockbuster IPO and AirBnB is expected to price later. Stocks edge up as politicians continue stimulus dance and the yuan hits new highs despite inflation dipping below zero for the first time in a decade. Here&rsquo s what you need to know in financial markets on Wednesday, December 9
th.
1. Pfizer allergic reaction
U.K. health regulators warned that people suffering from allergy issues should not take the vaccine developed by Pfizer (NYSE:
PFE) and BioNTech (NASDAQ:
BNTX), after two British healthcare professionals experienced allergic reactions to the drug after being inoculated earlier in the week. Both carers are recovering well, according to an official from the National Health Service for England.
The news comes only two days after the U.K. began a mass immunization program using the drug, and a day after the U.S. Food and Drug Administration said it had found no safety issues in an analysis of data from the companies&rsquo stage 3 trial. The FDA is expected to approve the drug for emergency use at a meeting on Thursday.
Elsewhere, the U.K. medical journal The Lancet published a peer review of the drug being developed by AstraZeneca (NASDAQ:
AZN) and the University of Oxford, confirming it has over an efficacy rate of over 70% - markedly less than the Pfizer/BioNTech and Moderna (NASDAQ:
MRNA) drugs, but enough to make it serviceable. Authorities in the United Arab Emirates confirmed that a drug developed by Chinese biotech company Sinopharm has an 86% efficacy rate.
https://sg.yahoo.com/news/masks-could-needed-another-warns-235633321.html
Masks could be needed for another year, warns government chief scientific adviser
